Yahoo
    Swiss - Delayed Quote CHF

    Roche Holding AG (RO.SW)

    405.00 -1.60 (-0.39%)
    As of 9:22:01 AM GMT+1. Market Open.
    Loading Chart for RO.SW
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Roche Secures FDA Clearance for New cobas eplex Respiratory Panel Detecting Up to 19 Pathogens

    Roche Secures FDA Clearance for New cobas eplex Respiratory Panel Detecting Up to 19 Pathogens
    InvestorsHub 16h ago
    RNA Targeting Small Molecule Drug Discovery Market - Global Strategic Business Report: Secure a US$5.3B Market by 2030 as Amgen, AstraZeneca, Roche and Merck Accelerate RNA Pipelines

    RNA Targeting Small Molecule Drug Discovery Market - Global Strategic Business Report: Secure a US$5.3B Market by 2030 as Amgen, AstraZeneca, Roche and Merck Accelerate RNA Pipelines
    GlobeNewswire 17h ago
    SIG vs. CFRUY: Which Stock Is the Better Value Option?

    SIG vs. CFRUY: Which Stock Is the Better Value Option?
    Zacks 17h ago
    Biotechnology Reagents - Global Strategic Business Report: Capture the US$60.7 Billion Market by 2032 as Thermo Fisher, Roche, Danaher, Merck, and Bio-Rad Drive Disruption

    Biotechnology Reagents - Global Strategic Business Report: Capture the US$60.7 Billion Market by 2032 as Thermo Fisher, Roche, Danaher, Merck, and Bio-Rad Drive Disruption
    GlobeNewswire 17h ago
    Roche receives FDA 510(k) clearance for new cobas® eplex respiratory pathogen panel 3, enabling labs to customize respiratory testing for local patient needs

    Roche receives FDA 510(k) clearance for new cobas® eplex respiratory pathogen panel 3, enabling labs to customize respiratory testing for local patient needs
    PR Newswire 18h ago
    UBS sees Roche giredestrant potential priced in after 50% share rally

    UBS sees Roche giredestrant potential priced in after 50% share rally
    Investing.com 21h ago
    FDA Decision Watch: Regeneron And Roche’s Autoimmune Drugs, Capricor’s DMD Therapy In Spotlight

    FDA Decision Watch: Regeneron And Roche’s Autoimmune Drugs, Capricor’s DMD Therapy In Spotlight
    Stocktwits 22h ago
    Novartis (SWX:NOVN) Reports Longer Survival In Advanced Kidney Cancer Trial

    Novartis (SWX:NOVN) Reports Longer Survival In Advanced Kidney Cancer Trial
    Simply Wall St. 1d ago
    Roche Holding (SWX:ROP) Expands ADC Pipeline As Late Stage Trial Results Impress

    Roche Holding (SWX:ROP) Expands ADC Pipeline As Late Stage Trial Results Impress
    Simply Wall St. 1d ago
    Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma

    Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma
    GlobeNewswire 6d ago
    Roche receives CE Mark for cobas® smart e immunoanalyser, completing a portfolio that brings central-lab precision to healthcare settings ranging from small clinics to large hospital laboratories

    Roche receives CE Mark for cobas® smart e immunoanalyser, completing a portfolio that brings central-lab precision to healthcare settings ranging from small clinics to large hospital laboratories
    GlobeNewswire 7d ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: